认知治疗和西酞普兰联合治疗对癌症抑郁患者的疗效观察  

The Efficacy of Citalopram and Cognitive Therapy on Cancer Patients with Depression

作　　者：高良会[1] 邓春继[1] 颜景祥[1] 蔡巧颖[2] 王海军[2] 齐战[3] 

机构地区：[1]河北省第六人民医院(保定),中国071000 [2]河北大学附属医院 [3]河北医科大学附属四院

出　　处：《中国健康心理学杂志》2012年第9期1300-1301,共2页China Journal of Health Psychology

摘　　要：目的探讨认知治疗和西酞普兰联合治疗对癌症抑郁患者疗效及生活质量的影响。方法对40例癌症抑郁患者进行8周的西酞普兰和认知治疗,采用汉密尔顿抑郁量表(HAMD),汉密尔顿焦虑量表(HAMA)和健康评定量表(SF-36)对两组患者进行治疗前后焦虑抑郁状态和生活质量的评估。结果 8周后患者焦虑、抑郁症状比入组时明显好转(P<0.01),患者生活质量中生理功能、总体健康、情感职能和精神健康明显改善。结论认知治疗和西酞普兰联合治疗能够降低癌症患者的抑郁和焦虑情绪,同时改善患者的健康状况,提高患者的生活质量。Objective To study the efficacy of citalopram and cognitive therapy on cancer patients with depression.Methods A total of 40 cancer patients with depression were treated with citalopram and cognitive therapy for 8 weeks.The efficacy and the quality of life were valuated with the HAMD,HAMA and SF-36 before and after treatment.Results After 8 weeks treatment,patients＇ scores of anxiety and depression decreased significantly as compared with the baseline（P0.01）,Patients＇ quality of life including physiological,general health,emotional intelligence and mental health showed a significant improvement as compared with baseline.Conclusion Citalopram and cognitive therapy can significantly reduce depression and anxiety of cancer patients.Furthermore,citalopram and cognitive therapy can also heighten patients＇ health state and improve patients＇ quality of life.

关 键 词：癌症 抑郁 生活质量 认知治疗 西酞普兰 

分 类 号：R749[医药卫生—神经病学与精神病学]